Drawing for CBC COMPREHENSIVE BIOMARKER CENTER

USPTO serial 79118333

CBC COMPREHENSIVE BIOMARKER CENTER

Reviewed by CopyMark Law Group

Reg. 4486693Status 404
Filing date
Status date
Registration date
Feb 25, 2014
Examiner
MICKLEBURGH, LINDA BOHANNON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CBC COMPREHENSIVE BIOMARKER CENTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035professional business consultation and business organization consultation in the market authorization of medicines and medical devices; planning and conducting of trade fairs for economic or advertising purposes; import-export agencies in the field of medicines and medical devices; wholesale store services and retail store services featuring medicines; business marketing services related to medicines and medical devices; commercial information and advice for consumers; wholesale store services in the chemical products sector featuring chemical and biochemical reagents for genetic analysis and testing; market reports and studiesSECTION 71 - CANCELLED—
042scientific and technological services, namely, scientific research, analysis and testing in the field of medicine, genetics and medical biomarkers; testing, analysis, and evaluation of medical diagnostic and biomarker preparations to assure compliance with industry standards; industrial chemical, biochemical, biological and bacteriological research and analysis; medical and scientific research information in the field of medicine, genetics and medical biomarkers; research and development of vaccines and medicines; design and testing for new product development, namely, pharmaceutical and diagnostic preparations and substances; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; testing, analyzing and evaluating new medicines; chemical research laboratories, pharmaceutical research laboratories, medical research laboratories, bacteriology research laboratories, molecular biological/biological research laboratories; medical and scientific research, namely, conducting clinical trials for others; scientific analyses in the field of chemistry, biology, molecular biology, pharmaceutics, and food technology; computer development of software in the field of the operation of therapeutic and diagnostic equipment and for the data processing for the purpose of imaging; scientific and technological services, namely, scientific research particular in the field of chemistry, genetics, biology, bioengineering, and biochemistry; chemical, biochemical, biological and bacteriological research and analysis; DNA and RNA analysis services, namely, development and research of DNA, RNA and scientific research in the field of biochemistry and biotechnology; scientific research; preparation of scientific opinions in the field of scientific research and development; advisory services relating to biotechnology, pharmaceutical research and development and genetic science; medical and scientific research, namely, the extraction or cultivation, scientific processing, and scientific analysis of biomaterials and compiling data for research purposes in the field of medical science and medical consultancy; contract research in the field of pharmacological and clinical development of medicines; scientific data analysis for scientific and technical purposes, namely, analysis of data originating from clinical trials; scientific laboratory services, namely, scientific development, research, identification, validation, analysis and interpretation of biomarkers, particularly nucleic acid based biomarkersSECTION 71 - CANCELLED—
044Medical services; veterinary services; hygienic and beauty care for human beings or animals; medical and veterinary diagnostic services in preclinical and clinical settings; medical and clinical examinationsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 13, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Nov 13, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 5, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jan 11, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 11, 2022INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Jun 9, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 28, 2014CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 23, 2014CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jun 27, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 11, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 10, 2014FIMPFINAL DISPOSITION PROCESSED—
May 25, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 6, 2014CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Apr 24, 2014CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Feb 25, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 2, 2014GPNXNOTIFICATION PROCESSED BY IB—
Dec 23, 2013CHLDCHANGE OF OWNER RECEIVED FROM IB—
Dec 10, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 20, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 20, 2013NPUBNOTICE OF PUBLICATION—
Nov 4, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 25, 2013ALIEASSIGNED TO LIE—
Oct 10, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 20, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 20, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2013CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 4, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 15, 2012RFNTREFUSAL PROCESSED BY IB—
Oct 22, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 22, 2012RFRRREFUSAL PROCESSED BY MPU—
Oct 20, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 19, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 15, 2012DOCKASSIGNED TO EXAMINER—
Oct 15, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 11, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance